Call runs ahead of the accounts: the business management describes is already operating beyond the period it is reportin
The model's full reasoning — Q2 2021 call → NOWe need to determine if there is a clear gap between the trailing period being reported and the level at which the business is already operating right now, as described by management. The transcript is for Q2 2021 results. Management discusses various developments: the DyDo license agreement contributed $2.7 million in revenue in Q2, but that's part of the reported period. They mention new patient enrollments, but that's also within the period. They talk about ongoing litigation, but that's not operational business. They mention hiring new executives, but that's not revenue-generating. They talk about business development activities, but no deals closed yet. They mention the long-acting formulation development, but that's future. They mention MuSK-MG trial, but they are reconsidering. They mention HNPP study not proceeding. So what is the "present is busier than the print"? They say "we are optimistic that as the country continues to recover from this pandemic, we anticipate that our Firdapse revenue trajectory will ramp further upward in the second half of this year and beyond." That's future. They also say "we are currently evaluating and conducting due diligence on what we believe are several very exciting opportunities to expand our portfolio" but no binding commitments. So that's pipeline. They mention the share repurchase program, but that's financial. They mention the patent issuance and litigation, but that's legal. They mention the CME course and fellows program, but that's educational. They mention the patient resources generating opt-ins, but that's marketing. None of these seem to indicate that the business is already operating at a higher level than the reported numbers. The reported numbers show growth, but management is not saying that the current run-rate is higher than the quarter's results. They are saying that COVID impacted the quarter and they expect recovery. That is a forward-looking statement, not a current gap. They also mention that new patient enrollments were 111% higher than same quarter last year, but that's within the quarter. They say "Q2 new patient enrollments were 111% higher for the quarter versus the same quarter last year." That's a comparison, not a gap between current and reported.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| YMM | Full Truck Alliance Co. Ltd. | Q2 2022 | 2022-08-25 | C+ |
| BFIN | BankFinancial Corporation | Q1 2022 | 2022-05-06 | A |
| ADSE | ADS-TEC Energy PLC | Q4 2021 | 2022-04-28 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| BFI | BurgerFi International, Inc. | Q3 2021 | 2021-11-12 | C |
BFI · Q3 2021 → YESThe question is whether there's a clear gap between the trailing period being reported (Q3 2021) and the current operating level, as told by management. YES The transcript shows management treating the Q3 results as trailing behind the combined company's current scale. Ian Baines opens by noting the November 3 acquisition closed just days before the call, immediately framing the business as now operating under the combined structure with 61 new locations. Julio Ramirez and Mike Rabinovitch repeatedly reference 2021 developments that occurred after September 30—10 new restaurant openings including one in October, 15 additional Ghost Kitchens, 32 signed leases, and the acquisition itself—as already-real activity driving the current state.
ADSE · Q4 2021 → YESThe question is: Is there a clear gap between the trailing period being reported and the level at which the business is already operating right now, such that management describes a company that has a...YES The transcript shows a clear gap. Management repeatedly frames the company as already operating at a higher level than the 2021 print: a €60 million+ order backlog (explicitly “year-to-date” and “just completed Q1”), U.S. business launched in late 2021 with “initial success … world orders received,” a signed ChargePost contract for 50 units with plans for >10,000 more, U.S. manufacturing plant search already underway with opening expected this year, service contracts expected to start in 2022, and new hires completed.
BFIN · Q1 2022 → YESThe question is whether there's a clear gap between the trailing period being reported (Q1 2022) and the current operating level, as described by management. YES The transcript shows management explicitly updating on April activity as already real and substantial, with loan growth hitting $45 million in April alone (pushing the portfolio over $1.1 billion), Equipment Finance originating more in April than the entire Q1, and overall originations at $148 million in April.